Skip to main content

Table 3 The overall survival rates at 1, 3, 5 and 8 year in groups stratified by methylation in tumor tissues (N = 307)

From: DNA methylation of SFRP1, SFRP2, and WIF1 and prognosis of postoperative colorectal cancer patients

Groups

1 year

3 year

5 year

8 year

OSR (SE) a

P value

OSR (SE)

P value

OSR (SE)

P value

OSR (SE)

P value

All patients (N = 307)

0.915 (0.018)

 

0.748 (0.027)

 

0.646 (0.028)

 

0.518 (0.039)

 

SFRP1

 

0.229

 

0.071

 

0.005

 

0.003

 Hypomethylation (N = 55)

0.872 (0.052)

 

0.660 (0.070)

 

0.472 (0.071)

 

0.258 (0.116)

 

 Hypermethylation (N = 252)

0.925 (0.019)

 

0.767 (0.030)

 

0.683 (0.031)

 

0.562 (0.042)

 

SFRP2

 

0.205

 

0.015

 

0.001

 

0.000

 Hypomethylation (N = 246)

0.905 (0.021)

 

0.720 (0.031)

 

0.603 (0.032)

 

0.455 (0.048)

 

 Hypermethylation (N = 43)

0.976 (0.023)

 

0.928 (0.040)

 

0.904 (0.046)

 

0.822 (0.062)

 

WIF1

 

0.044

 

0.477

 

0.793

 

0.598

 Hypomethylation (N = 224)

0.932 (0.020)

 

0.755 (0.032)

 

0.627 (0.034)

 

0.491 (0.046)

 

 Hypermethylation (N = 83)

0.868 (0.041)

 

0.730 (0.055)

 

0.700 (0.051)

 

0.595 (0.073)

 

Co-methylation-2

 

0.205

 

0.015

 

0.001

 

0.000

 Co-methylation-2 L b

0.905 (0.020)

 

0.720 (0.031)

 

0.603 (0.032)

 

0.462 (0.044)

 

 Co-methylation-2H c

0.976 (0.023)

 

0.928 (0.040)

 

0.904 (0.046)

 

0.822 (0.062)

 

Co-methylation-3

 

0.624

 

0.111

 

0.013

 

0.004

 Co-methylation-3 L d

0.912 (0.019)

 

0.735 (0.029)

 

0.623 (0.030)

 

0.493 (0.039)

 

 Co-methylation-3H e

0.957 (0.043)

 

0.913 (0.059)

 

0.913 (0.059)

 

0.852 (0.080)

 
  1. aOverall Survival Rate (Standard Error)
  2. bCo-methylation-2 L: patients with promoter hypomethylation of at least one gene (SFRP1 or SFRP2)
  3. cCo-methylation-2H: patients with promoter hypermethylation of SFRP1 and SFRP2
  4. dCo-methylation-3 L: patients with promoter hypomethylation of at least one gene (SFRP1 or SFRP2 or WIF1)
  5. eCo-methylation-3H: patients with promoter hypermethylation of SFRP1, SFRP2 and WIF1